Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
Jiangsu Hengrui Pharmaceuticals (01276): HRS-7156 tablets receive approval notification for clinical trials of drug.
AAC TECH spent HK$10.8425 million to buy back 300,000 shares on April 15th.
China Merchants Bank (03968) completed the issuance of 30 billion yuan of perpetual capital bonds.
Jiangsu Hengrui Pharmaceuticals (01276): HRS-7156 tablets receive approval notification for clinical trials of drug.
AAC TECH spent HK$10.8425 million to buy back 300,000 shares on April 15th.
China Merchants Bank (03968) completed the issuance of 30 billion yuan of perpetual capital bonds.
